First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2025.02.008 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Anna Pawłowska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hypertension, and Internal Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections, Antiviral Agents, Ribonucleosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Cytomegalovirus (CMV) is one of the most common opportunistic infections affecting solid organ transplant recipients (SOTRs). In this article, we presented the case of a 39-year-old patient with end-stage renal disease after kidney transplantation with refractory CMV infection, who was successfully treated with maribavir for the first time in Poland. The use of maribavir resulted in a significant reduction of CMV viremia in ganciclovir/valganciclovir-resistant CMV infection and resolution of CMV disease symptoms in the absence of drug-related adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Hypertension, and Internal Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
- Department of Nephrology, Hypertension, and Internal Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland. Electronic address: stompin@mp.pl.
Zitieren
APA
Pawłowska, A., Kwella, N., Zbrzeźniak-Suszczewicz, J., Knysak, M., & Stompór, T. (2025). First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.02.008
Vancouver
Pawłowska A, Kwella N, Zbrzeźniak-Suszczewicz J, Knysak M, Stompór T. First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.02.008
BibTeX
@article{Pawowska2025,
author = {Pawłowska, Anna and Kwella, Norbert and Zbrzeźniak-Suszczewicz, Justyna and Knysak, Monika and Stompór, Tomasz},
title = {First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2025.02.008}
}
EUVIMED